Nyhet

Cereno’s CEO: “very excited for topline readout!”

Nyheter Biostock (extern källa)

Nyhet från Biostock

Publicerad: 29 Aug 2024 13:52

Cereno Scientific has released its Q2 report for 2024, highlighting the company’s advancements in developing cardiovascular disease treatments.

CEO Sten R Sörensen came by the BioStock Studio to discuss the main takeaways from the period and take a sneak peak into what’s to come for the company during Q3.

Lorem ipsum dolor sit amet. Est omnis iusto eos velit nostrum et pariatur quod non. Consequuntur nemo id dolores tempora ut quis quis eum. Porro dolore rem voluptas iste. Consequuntur nemo id dolores tempora ut quis quis eum

•Denna källa har få eller inga artiklar bakom betalvägg

Läs hela artikeln hos Biostock

Börskollen

För dig med koll på börsen

Nyhet

Cereno’s CEO: “very excited for topline readout!”

Nyhetsbrev